Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Iscience|February 18, 2026
Safety, immunogenicity, and optimal dosing of VLPCOV-02, a SARS-CoV-2 saRNA vaccine with modified 5-methylcytosine baseMasayuki Aboshi, Daisuke Kawakami, Kaoru Kono, et al.Vaccine|October 17, 2009
Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primatesJay W Hooper, Anthony M Ferro, Joseph W Golden, et al.The American Journal of Tropical Medicine and Hygiene|October 5, 2002
An outbreak of West Nile virus in a New York City captive wildlife populationGeorge V Ludwig, Paul P Calle, Joseph A Mangiafico, et al.Iscience|February 14, 2024
Safety and immunogenicity of VLPCOV-02, a SARS-CoV-2 self-amplifying RNA vaccine with a modified base, 5-methylcytosineMasayuki Aboshi, Kenta Matsuda, Daisuke Kawakami, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|June 11, 2025
Lyophilized SARS-CoV-2 self-amplifying RNA vaccines for microneedle Array patch deliveryMadison M Driskill, Ian A Coates, Paul J Hurst, et al.Journal of Virology|April 22, 2024
A tetravalent dengue virus-like particle vaccine induces high levels of neutralizing antibodies and reduces dengue replication in non-human primatesDaniel Thoresen, Kenta Matsuda, Akane Urakami, et al.Vaccine|October 27, 2007
Development and preclinical evaluation of an alphavirus replicon vaccine for influenzaBolyn Hubby, Todd Talarico, Maureen Maughan, et al.Nature Communications|May 19, 2023
saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concernMai Komori, Takuto Nogimori, Amber L Morey, et al.Cell Reports. Medicine|August 16, 2023
Safety and immunogenicity of SARS-CoV-2 self-amplifying RNA vaccine expressing an anchored RBD: A randomized, observer-blind phase 1 studyWataru Akahata, Takashi Sekida, Takuto Nogimori, et al.Science Translational Medicine|November 12, 2025
Incorporation of 5-methylcytidine alleviates RIG-I-mediated innate immune responses to a self-amplifying RNA vaccineWataru Akahata, Mai Komori, Amber L Morey, et al.Pageof 3